Biodel Inc (NASDAQ:BIOD)
| 3.71 Data as of May 24 |  +0.03 / +0.82%Today’s Change | 2.13 Today|||52-Week Range 3.82 | +57.87% Year-to-Date |
Latest BIOD News | Press Releases
No recent news for Biodel Inc.
Today’s Trading
| Previous close | 3.68 |
| Today’s open | 3.72 |
| Day’s range | 3.65 - 3.78 |
| Volume | 91,557 |
| Average volume (3 months) | 66,989 |
| Market cap | $52.8M |
| Dividend yield | -- |
Data as of 3:59pm ET, 05/24/2013
Growth & Valuation
| Earnings growth (last year) | -40.44% |
| Earnings growth (this year) | +28.66% |
| Earnings growth (next 5 years) | +23.70% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.70 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CMXICytomedix Inc | +0.01 | +2.04% |
| VTUSVentrus Biosciences ... | -0.10 | -3.62% |
| ATNMCactus Ventures Inc | -0.03 | -0.77% |
| CBRXColumbia Laboratorie... | -0.00 | -0.16% |
Data as of 4:00pm ET, 05/24/2013
Financials
| Next reporting date | August 7, 2013 |
| EPS forecast (this quarter) | -$0.37 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$20.7M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
President, Chief Executive Officer & Director Errol B. De Souza, PhD |
Vice President- Operations Eric I. Steiner, MD, MBA |
Corporate headquarters Danbury, Connecticut |
Forecasts
